David House

David House was appointed Senior Vice President, Finance and Principal Financial Officer on August 16, 2024. Previously, Mr. House served as Corporate Controller and Vice President of Accounting at ZO Skin Health, Inc., a multi-channel physician-dispensed skincare company, from October 2018 to May 2024. At ZO Skin Health, he led global accounting operations, managed financial reporting, and played a crucial role in the company’s acquisition by Blackstone. He also established international subsidiaries and oversaw financial integration for mergers and acquisitions. Mr. House’s experience includes similar financial leadership roles at Peregrine Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, and Avid Bioservices, Inc., a contract development and manufacturing organization, where he served as Controller and was responsible for implementing ASC 606, managing technical accounting, and conducting Securities and Exchange Commissionreporting. Mr. House’s career also includes roles at Viant, Inc. (NASDAQ: DSP), Sourcing Solutions, LLC, and Apria Healthcare, where he held various accounting and financial management positions. In the early stages of his career, Mr. House worked as a Senior Auditor at Windes & McClaughry Accountancy Corp., a public accounting firm. There, he managed comprehensive audits for public, private, and not-for-profit entities and contributed to SEC filings and internal control evaluations. Mr. House holds a Bachelor of Arts in Business Administration with an Accounting concentration from California State University, Fullerton. He obtained his California Certified Public Accountant license, which is currently inactive.